- Home
- RLAY vs TRIP Comparison
RLAY vs TRIP Comparison
Compare RLAY & TRIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLAY | TRIP |
|---|---|---|
| Founded | 2015 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 2020 | 2011 |
Fundamental Metrics
Financial Performance| Metric | RLAY | TRIP |
|---|---|---|
| Price | $14.96 | $10.93 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 13 |
| Target Price | ★ $17.38 | $14.58 |
| AVG Volume (30 Days) | 2.8M | ★ 4.2M |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 31.78 | ★ 675.00 |
| EPS | N/A | ★ 0.31 |
| Revenue | $15,355,000.00 | ★ $1,556,000,000.00 |
| Revenue This Year | N/A | $3.33 |
| Revenue Next Year | $324.03 | $5.12 |
| P/E Ratio | ★ N/A | $37.00 |
| Revenue Growth | ★ 53.44 | N/A |
| 52 Week Low | $2.30 | $9.01 |
| 52 Week High | $15.00 | $20.16 |
Technical Indicators
Market Signals| Indicator | RLAY | TRIP |
|---|---|---|
| Relative Strength Index (RSI) | 80.08 | 55.37 |
| Support Level | $6.42 | $9.36 |
| Resistance Level | N/A | $11.08 |
| Average True Range (ATR) | 0.86 | 0.58 |
| MACD | 0.52 | 0.19 |
| Stochastic Oscillator | 92.28 | 70.51 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About TRIP TripAdvisor Inc.
Tripadvisor is the world's leading travel metasearch company. Its platform offers 1 billion reviews and information on several million accommodations, restaurants, experiences, airlines, and cruises. In 2025, 42% of revenue came from the company's core Hotel and Other segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 46% of revenue in 2025, and TheFork, its dining brand, represented 12% of sales.